NYSCF Scientific Discovery Biobank
Part of paid clinical trials in New York, New York.
- Sponsor
- New York Stem Cell Foundation Research Institute
- Study ID
- NCT06203106
- Status
- Recruiting
Conditions
- ALS
- Alzheimer Disease
- Alzheimer Disease, Early Onset
- Alzheimer Disease, Late Onset
- Amyotrophic Lateral Sclerosis
- Batten Disease
- Cervical Cancer
- Corticobasal Degeneration
- Dementia
- Diabetes
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Frontotemporal Dementia
- Huntington Disease
- INAD
- Lewy Body Disease
- Macular Degeneration
- Multiple Sclerosis
- Multiple System Atrophy
- Ovarian Cancer
- PTSD
- Parkinson Disease
- Parkinson's Disease and Parkinsonism
- Post Traumatic Stress Disorder
- Progressive Supranuclear Palsy
- Uterine Cancer
- Vaginal Cancer
- Vulvar Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 30 Days - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Biological Sample Collection — OTHERSkin biopsy (2-3mm) and/or blood (up to 50 mL); saliva; excess/ leftover biospecimens that were (or will be) collected for other purposes (e.g., medical procedure).
Study Details
The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate diverse disease research using cells from the body (such as skin or blood cells) to make stem cells and other types of cells, conduct research on the samples, perform genetic testing, and store the samples for future use. Through this research, researchers hope to identify future treatments or even cures for the major diseases of our time.
Key Dates
- First listed
- Jan 12, 2024
- Start date
- Nov 10, 2022
- Status verified
- Feb 2025
- Primary completion
- Nov 10, 2045
- Completion
- Nov 10, 2045
Study Design
- Enrollment
- 10,000 participants (estimated)
Arms
- Arm: Affected SubjectsSubjects in this group will have a diagnosis and/or medical history of a condition, disease, genetic background, or trait of interest.
- Arm: Healthy ControlSubjects in this group will serve as healthy controls.
Primary Outcome Measure
Biobank [ Time Frame: Baseline ]
Central Contacts
- Clinical Research Office212-927-1801
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| New York Stem Cell Foundation Research Institute | New York | New York | 10019 | Laura Andres-Martin, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in New York, NY
Nationwide
Alzheimer's disease trialsCervical cancer trialsType 1 diabetes trialsType 2 diabetes trialsHuntington disease trialsAge-related macular degeneration trialsMultiple sclerosis trialsOvarian cancer trialsPTSD (post-traumatic stress disorder) trialsParkinson's disease trialsEndometrial cancer trialsNeurology trialsDementia care trialsBrain disorders trialsGeriatrics trialsOncology trialsGynecologic oncology trialsWomen's health trialsEndocrinology trialsMetabolic health trialsWeight loss trialsOphthalmology trialsRetina trialsAutoimmune disease trialsPsychiatry trialsMental health trialsBehavioral health trials
By condition
By specialty
By research site
Related Studies
- TrialNet Pathway to Prevention of T1DRecruiting · University of South Florida · Orange, California
- Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk WomenRecruiting · M.D. Anderson Cancer Center · Miami, Florida
- Genes and Environment in Multiple SclerosisRecruiting · Columbia University · Bethesda, Maryland
- Natural History Study of SynucleinopathiesRecruiting · NYU Langone Health · Boston, Massachusetts